oxybutynin and piroxicam

oxybutynin has been researched along with piroxicam in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Eid, SF; El-Houseny, SS; Nesseem, DI1
Cun, D; Fang, L; Guan, Y; Li, Y; Xi, H; Xiang, R; Zhang, Y1
Chantasart, D; Junyaprasert, VB; Teeranachaideekul, V; Tocanitchart, P; Wongrakpanich, A1
Ali, FR; Hashmat, D; Shoaib, MH; Siddiqui, F1

Reviews

1 review(s) available for oxybutynin and piroxicam

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for oxybutynin and piroxicam

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Development of novel transdermal self-adhesive films for tenoxicam, an anti-inflammatory drug.
    Life sciences, 2011, Sep-26, Volume: 89, Issue:13-14

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Lower Extremity; Male; Methacrylates; Piroxicam; Polyethylene Glycols; Polymers; Propylene Glycol; Rats; Rats, Wistar; Skin; Transdermal Patch

2011
Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment?
    Journal of controlled release : official journal of the Controlled Release Society, 2013, Jul-10, Volume: 169, Issue:1-2

    Topics: Administration, Cutaneous; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Crotonates; Hydroxybutyrates; Male; Nitriles; Piroxicam; Rabbits; Rats; Toluidines; Transdermal Patch

2013
Fabrication and evaluation of Eudragit
    Pharmaceutical development and technology, 2018, Volume: 23, Issue:8

    Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Delivery Systems; Epidermis; Female; Humans; Middle Aged; Piroxicam; Polyethylene Glycols; Polymethacrylic Acids; Polyvinyl Alcohol; Skin Absorption; Transdermal Patch

2018
Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers.
    PloS one, 2020, Volume: 15, Issue:2

    Topics: Administration, Cutaneous; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Gels; Male; Oleic Acid; Piroxicam; Propylene Glycol; Rats; Rats, Wistar; Skin; Skin Absorption; Solvents; Transdermal Patch

2020